SecBot SecBot
8-K ·Filed Jun 30, 2026

SSII

SS Innovations International, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001213900-26-073399
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

This is a routine industry award announcement with no financial data — no immediate trading catalyst. Monitor upcoming quarterly filings for revenue growth and system placement metrics to gauge commercial traction.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
SSII ▼ -25.06% at T+60d
NEUTRAL call -25.06% · α vs SPY -28.62% · entry $4.15 → $3.11
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
-5.06%
call -5.06% · α -4.92%
$3.94
settled 4mo ago
T+5d
-10.12%
call -10.12% · α -10.72%
$3.73
settled 4mo ago
T+20d
-4.58%
call -4.58% · α -3.55%
$3.96
settled 3mo ago
T+60d
-25.06%
call -25.06% · α -28.62%
$3.11
settled 5w ago

Price Chart

Loading chart...

Executive Summary

SS Innovations filed an 8-K announcing it won the 'Outstanding Company' category at the 2026 Surgical Robotics Industry Awards. The press release also disclosed cumulative procedure volume of 11,719 surgeries on its SSi Mantra system as of June 22, 2026, and regulatory approvals in 14 countries. This is a non-financial industry award with no material financial data or guidance provided.

Key Facts

  • SS Innovations won the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, beating nine other finalists.
  • Cumulative multi-specialty procedures on the SSi Mantra system totaled 11,719 as of June 22, 2026, including 612 cardiac, 175 telesurgeries, and 212 pediatric surgeries.
  • Approximately 2,100 physicians have been trained on the SSi Mantra, which has performed over 170 different procedure types.
  • The SSi Mantra has regulatory approval in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, Philippines, Sri Lanka, Ukraine, and UAE.
  • No financial figures (revenue, earnings, guidance, or deal values) were disclosed in the filing.

Financial Impact

No financial impact disclosed. The filing contains no revenue, earnings, or guidance figures.

Risk Factors

  • No financial data provided — commercial success cannot be assessed from this filing alone.
  • Regulatory approvals are limited to 14 countries, mostly emerging markets; lack of FDA clearance or CE mark limits addressable market.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-073399
Document: ea029635901ex99-1.htm0001213900-26-073399
Document: 0001213900-26-073399-index-headers.html0001213900-26-073399
Document: 0001213900-26-073399-index.html0001213900-26-073399
Document: 0001213900-26-073399.txt0001213900-26-073399
22 reports for SSII
Performance horizon
60% Hit rate @ T+5 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+20▲ +15.17%May 20, 2026
Filters
Rows
Reports for SSII — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
8-K
NEUTRAL ★ 3/10
$2.37awaiting T+5—$2.50 (+5.49%)
Oct 26, 2026
1d ago
Press Release
NEUTRAL ★ 3/10
$2.37awaiting T+5—$2.50 (+5.49%)
Oct 13, 2026
14d ago
8-K
NEUTRAL ★ 4/10
$2.55 $2.54▼ −0.39%▲ +0.76%$2.50 (−1.96%)
Oct 13, 2026
14d ago
8-K
BEARISH ★ 6/10
$2.55 $2.54▲ +0.39%▼ −0.76%$2.50 (+1.96%)
Oct 9, 2026
18d ago
424B5
BEARISH ★ 6/10
$2.55 $2.45▲ +3.92%▲ +2.43%$2.50 (+1.96%)
Oct 5, 2026
22d ago
8-K
NEUTRAL ★ 4/10
$2.77 $2.55▼ −7.94%▼ −8.36%$2.50 (−9.75%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$3.30 $3.26▼ −1.21%▼ −0.71%$2.50 (−24.24%)
Aug 13, 2026
10w ago
8-K
MIXED ★ 6/10
$3.83 $3.61▼ −5.74%▼ −3.78%$2.50 (−34.73%)
Jul 17, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$3.64 $3.57▼ −1.92%▼ −1.24%$2.50 (−31.32%)
Jul 14, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$3.67 $3.75▲ +2.18%▲ +3.48%$2.50 (−31.88%)
Showing 10 of 22

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026